Ischemia-modified albumin (IMA): Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
Latest revision as of 18:42, 4 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Ischemia-modified albumin (IMA) is a test for ischemia that is based on the observation that the affinity of the N-terminus of human albumin for cobalt is reduced in patients with myocardial ischemia.(1) Preliminary studies suggest that it is a sensitive and early detector of chest pain of ischemic etiology,(1-5) as well as of transient myocardial ischemia peri-PCI.(6),(7)
References
- ref1 PMID 11074321
- ref2 PMID 11238298
- ref3 PMID 12213987
- ref4 PMID 12651810
- ref5 PMID 12651803
- ref6 PMID 11376314
- ref7 PMID 12742986